Drug archive
Teniposide (Systemic)
Archived drug information. This USP DI monograph is kept for reference and dates from the mid-2000s. Doses, warnings, interactions and brand names may have changed, and some products are no longer sold. Always follow your prescriber, your pharmacist and the current label, for example on DailyMed.
Category
- Antineoplastic
Description
Teniposide (ten-i-POE-side) belongs to the group of medicines called antineoplastics. Teniposide injection is used along with other medicines to treat acute lymphoblastic leukemia (ALL), non-Hodgkin's lymphoma (NHL), and neuroblastoma.
Teniposide interferes with the growth of cancer cells, which are eventually destroyed. Since the growth of normal body cells may also be affected by teniposide, other effects will also occur. Some of these may be serious and must be reported to your doctor. Other effects may not be serious but may cause concern.
Teniposide is to be administered only by or under the immediate supervision of your doctor. It is available in the following dosage form:
- Injection (U.S. and Canada)
Brand Names
Some commonly used brand names are:
In the U.S. -
- Vumon
In Canada -
- Vumon
Another commonly used name is VM-26 .